Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S).
Saved in:
| Title: | Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S). |
|---|---|
| Authors: | Luvira V; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Lawpoolsri S; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand., Phumratanaprapin W; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Jongkaewwattana A; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand., Nanthapisal S; Faculty of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, Thailand., Muangnoicharoen S; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Kamolratanakul S; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Sabmee Y; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Duangdee C; Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Narakorn P; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand., Surichan S; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand., Mercer LD; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Raghunandan R; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Polyak CS; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Wirachwong P; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand., Flores J; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Pitisuttithum P; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Electronic address: punnee.pit@mahidol.ac.th. |
| Source: | Vaccine [Vaccine] 2025 Aug 30; Vol. 62, pp. 127601. Date of Electronic Publication: 2025 Aug 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40789265 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Luvira+V%22">Luvira V</searchLink>; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Lawpoolsri+S%22">Lawpoolsri S</searchLink>; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Phumratanaprapin+W%22">Phumratanaprapin W</searchLink>; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Jongkaewwattana+A%22">Jongkaewwattana A</searchLink>; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand.<br /><searchLink fieldCode="AU" term="%22Nanthapisal+S%22">Nanthapisal S</searchLink>; Faculty of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, Thailand.<br /><searchLink fieldCode="AU" term="%22Muangnoicharoen+S%22">Muangnoicharoen S</searchLink>; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Kamolratanakul+S%22">Kamolratanakul S</searchLink>; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Sabmee+Y%22">Sabmee Y</searchLink>; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Duangdee+C%22">Duangdee C</searchLink>; Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Narakorn+P%22">Narakorn P</searchLink>; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Surichan+S%22">Surichan S</searchLink>; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Mercer+LD%22">Mercer LD</searchLink>; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.<br /><searchLink fieldCode="AU" term="%22Raghunandan+R%22">Raghunandan R</searchLink>; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.<br /><searchLink fieldCode="AU" term="%22Polyak+CS%22">Polyak CS</searchLink>; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.<br /><searchLink fieldCode="AU" term="%22Wirachwong+P%22">Wirachwong P</searchLink>; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Flores+J%22">Flores J</searchLink>; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.<br /><searchLink fieldCode="AU" term="%22Pitisuttithum+P%22">Pitisuttithum P</searchLink>; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Electronic address: punnee.pit@mahidol.ac.th. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2025 Aug 30; Vol. 62, pp. 127601. <i>Date of Electronic Publication: </i>2025 Aug 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40789265 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2025.127601 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 127601 Titles: – TitleFull: Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Luvira V – PersonEntity: Name: NameFull: Lawpoolsri S – PersonEntity: Name: NameFull: Phumratanaprapin W – PersonEntity: Name: NameFull: Jongkaewwattana A – PersonEntity: Name: NameFull: Nanthapisal S – PersonEntity: Name: NameFull: Muangnoicharoen S – PersonEntity: Name: NameFull: Kamolratanakul S – PersonEntity: Name: NameFull: Sabmee Y – PersonEntity: Name: NameFull: Duangdee C – PersonEntity: Name: NameFull: Narakorn P – PersonEntity: Name: NameFull: Surichan S – PersonEntity: Name: NameFull: Mercer LD – PersonEntity: Name: NameFull: Raghunandan R – PersonEntity: Name: NameFull: Polyak CS – PersonEntity: Name: NameFull: Wirachwong P – PersonEntity: Name: NameFull: Flores J – PersonEntity: Name: NameFull: Pitisuttithum P IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 08 Text: 2025 Aug 30 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 62 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
